申请人:Cox Christopher D.
公开号:US20110319409A1
公开(公告)日:2011-12-29
The present invention is directed to 7-aza-quinazoline compounds of general structural formula I
which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10).
本发明涉及一般结构式I的7-aza-喹唑啉化合物,可用作治疗与磷酸二酯酶10(PDE10)相关的中枢神经系统疾病的治疗剂。